Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

This study has been completed.
Information provided by (Responsible Party):
Piramal Enterprises Limited Identifier:
First received: December 7, 2010
Last updated: November 21, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)